Cargando…
Immunotherapy in oncology and the kidneys: a clinical review of the evaluation and management of kidney immune-related adverse events
Immune checkpoint inhibitors (ICI) are now widely used in the treatment of many cancers, and currently represent the standard of care for multiple malignancies. These agents enhance the T cell immune response to target cancer tissues, and have demonstrated considerable benefits for cancer outcomes....
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229281/ https://www.ncbi.nlm.nih.gov/pubmed/37261008 http://dx.doi.org/10.1093/ckj/sfad014 |